Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment

Diabetic wounds are imbued with an early excessive and protracted reactive oxygen species production. Despite the studies supporting PPARβ/δ as a valuable pharmacologic wound-healing target, the therapeutic potential of PPARβ/δ agonist GW501516 (GW) as a wound healing drug was never investigated. Us...

Full description

Bibliographic Details
Main Authors: Choong, Cleo Swee Neo, Tan, Nguan Soon, Wang, Xiaoling, Sng, Ming Keat, Foo, Selin, Chong, Han Chung, Lee, Wei Li, Tang, Mark Boon Yang, Ng, Kee Woei, Luo, Baiwen, Wong, Marcus Thien Chong, Tong, Benny Meng Kiat, Chiba, Shunsuke, Loo, Say Chye Joachim, Zhu, Pengcheng
Other Authors: School of Materials Science & Engineering
Format: Journal Article
Language:English
Published: 2015
Subjects:
Online Access:https://hdl.handle.net/10356/100134
http://hdl.handle.net/10220/25674
_version_ 1826119995934900224
author Choong, Cleo Swee Neo
Tan, Nguan Soon
Wang, Xiaoling
Sng, Ming Keat
Foo, Selin
Chong, Han Chung
Lee, Wei Li
Tang, Mark Boon Yang
Ng, Kee Woei
Luo, Baiwen
Wong, Marcus Thien Chong
Tong, Benny Meng Kiat
Chiba, Shunsuke
Loo, Say Chye Joachim
Zhu, Pengcheng
author2 School of Materials Science & Engineering
author_facet School of Materials Science & Engineering
Choong, Cleo Swee Neo
Tan, Nguan Soon
Wang, Xiaoling
Sng, Ming Keat
Foo, Selin
Chong, Han Chung
Lee, Wei Li
Tang, Mark Boon Yang
Ng, Kee Woei
Luo, Baiwen
Wong, Marcus Thien Chong
Tong, Benny Meng Kiat
Chiba, Shunsuke
Loo, Say Chye Joachim
Zhu, Pengcheng
author_sort Choong, Cleo Swee Neo
collection NTU
description Diabetic wounds are imbued with an early excessive and protracted reactive oxygen species production. Despite the studies supporting PPARβ/δ as a valuable pharmacologic wound-healing target, the therapeutic potential of PPARβ/δ agonist GW501516 (GW) as a wound healing drug was never investigated. Using topical application of polymer-encapsulated GW, we revealed that different drug release profiles can significantly influence the therapeutic efficacy of GW and consequently diabetic wound closure. We showed that double-layer encapsulated GW microparticles (PLLA:PLGA:GW) provided an earlier and sustained dose of GW to the wound and reduced the oxidative wound microenvironment to accelerate healing, in contrast to single-layered PLLA:GW microparticles. The underlying mechanism involved an early GW-mediated activation of PPARβ/δ that stimulated GPx1 and catalase expression in fibroblasts. GPx1 and catalase scavenged excessive H2O2 accumulation in diabetic wound beds, prevented H2O2-induced ECM modification and facilitated keratinocyte migration. The microparticles with early and sustained rate of GW release had better therapeutic wound healing activity. The present study underscores the importance of drug release kinetics on the therapeutic efficacy of the drug and warrants investigations to better appreciate the full potential of controlled drug release.
first_indexed 2024-10-01T05:09:17Z
format Journal Article
id ntu-10356/100134
institution Nanyang Technological University
language English
last_indexed 2024-10-01T05:09:17Z
publishDate 2015
record_format dspace
spelling ntu-10356/1001342023-02-28T17:02:33Z Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment Choong, Cleo Swee Neo Tan, Nguan Soon Wang, Xiaoling Sng, Ming Keat Foo, Selin Chong, Han Chung Lee, Wei Li Tang, Mark Boon Yang Ng, Kee Woei Luo, Baiwen Wong, Marcus Thien Chong Tong, Benny Meng Kiat Chiba, Shunsuke Loo, Say Chye Joachim Zhu, Pengcheng School of Materials Science & Engineering School of Biological Sciences School of Physical and Mathematical Sciences DRNTU::Science::Biological sciences::Human anatomy and physiology Diabetic wounds are imbued with an early excessive and protracted reactive oxygen species production. Despite the studies supporting PPARβ/δ as a valuable pharmacologic wound-healing target, the therapeutic potential of PPARβ/δ agonist GW501516 (GW) as a wound healing drug was never investigated. Using topical application of polymer-encapsulated GW, we revealed that different drug release profiles can significantly influence the therapeutic efficacy of GW and consequently diabetic wound closure. We showed that double-layer encapsulated GW microparticles (PLLA:PLGA:GW) provided an earlier and sustained dose of GW to the wound and reduced the oxidative wound microenvironment to accelerate healing, in contrast to single-layered PLLA:GW microparticles. The underlying mechanism involved an early GW-mediated activation of PPARβ/δ that stimulated GPx1 and catalase expression in fibroblasts. GPx1 and catalase scavenged excessive H2O2 accumulation in diabetic wound beds, prevented H2O2-induced ECM modification and facilitated keratinocyte migration. The microparticles with early and sustained rate of GW release had better therapeutic wound healing activity. The present study underscores the importance of drug release kinetics on the therapeutic efficacy of the drug and warrants investigations to better appreciate the full potential of controlled drug release. Accepted version 2015-05-26T01:02:54Z 2019-12-06T20:17:16Z 2015-05-26T01:02:54Z 2019-12-06T20:17:16Z 2015 2015 Journal Article Wang, X., Sng, M. K., Foo, S., Chong, H. C., Lee, W. L., Tang, M. B. Y., et al. (2014). Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment. Journal of controlled release, 197, 138-147. 0168-3659 https://hdl.handle.net/10356/100134 http://hdl.handle.net/10220/25674 10.1016/j.jconrel.2014.11.001 en Journal of controlled release © 2014 Elsevier. This is the author created version of a work that has been peer reviewed and accepted for publication by Journal of Controlled Release, Elsevier. It incorporates referee’s comments but changes resulting from the publishing process, such as copyediting, structural formatting, may not be reflected in this document. The published version is available at: [http://dx.doi.org/10.1016/j.jconrel.2014.11.001]. application/pdf
spellingShingle DRNTU::Science::Biological sciences::Human anatomy and physiology
Choong, Cleo Swee Neo
Tan, Nguan Soon
Wang, Xiaoling
Sng, Ming Keat
Foo, Selin
Chong, Han Chung
Lee, Wei Li
Tang, Mark Boon Yang
Ng, Kee Woei
Luo, Baiwen
Wong, Marcus Thien Chong
Tong, Benny Meng Kiat
Chiba, Shunsuke
Loo, Say Chye Joachim
Zhu, Pengcheng
Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
title Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
title_full Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
title_fullStr Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
title_full_unstemmed Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
title_short Early controlled release of peroxisome proliferator-activated receptor β/δ agonist GW501516 improves diabetic wound healing through redox modulation of wound microenvironment
title_sort early controlled release of peroxisome proliferator activated receptor β δ agonist gw501516 improves diabetic wound healing through redox modulation of wound microenvironment
topic DRNTU::Science::Biological sciences::Human anatomy and physiology
url https://hdl.handle.net/10356/100134
http://hdl.handle.net/10220/25674
work_keys_str_mv AT choongcleosweeneo earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT tannguansoon earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT wangxiaoling earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT sngmingkeat earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT fooselin earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT chonghanchung earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT leeweili earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT tangmarkboonyang earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT ngkeewoei earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT luobaiwen earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT wongmarcusthienchong earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT tongbennymengkiat earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT chibashunsuke earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT loosaychyejoachim earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment
AT zhupengcheng earlycontrolledreleaseofperoxisomeproliferatoractivatedreceptorbdagonistgw501516improvesdiabeticwoundhealingthroughredoxmodulationofwoundmicroenvironment